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Acute respiratory distress syndrome
Prognosis of ARDS is not only related to physiological
alterations and therapeutic strategies but to the underlying
disease. Patients with malignancies and ARDS have re-
ceived less attention. Outcomes were studied in a huge
cohort of more than 1,000 patients with mainly haema-
tological malignancies and infection-induced ARDS [1].
The most important point was that survival improved over
time. The authors outlined the fact that non-invasive
ventilation was used in 30 % of the patients but failed in
70 % of these. An important point corroborating epi-
demiological studies done in other categories of patients
with acute respiratory failure was that non-invasive ven-
tilation failure was associated with a worse outcome.
The use of chest computed tomography is sometimes
limited by the repetitive exposure to radiation. In a
comparative study including 45 ARDS patients, reducing
radiation by 70 % did not alter quantitative and visual
anatomical analysis [2].
Recruitment manoeuvres still represent a controversial
issue in the symptomatic treatment of hypoxaemia in
ARDS. A systematic review and meta-analysis [3] in-
cluding ten randomised clinical trials (RCTs) reported a
reduction in hospital mortality by the use of recruitment
manoeuvres. However the quality of evidence was judged
to be low because of the risk of bias in the included
studies and the fact that other therapeutic strategies were
concomitantly used. The use of recruitment manoeuvres
in ARDS patients is still a matter of debate.
The exact mechanisms explaining how prone posi-
tioning improves gas exchange and, more importantly,
patient outcome in ARDS are largely unknown. Prone
position exerts various beneficial effects regarding the
ventilation–perfusion relationship. In a detailed review
Guerin et al. [4] described the proposed beneficial
mechanisms in ARDS patients, making the point that
prevention of ventilator-induced lung injury and im-
provement in haemodynamics likely contribute. There are
several hypotheses to explain the discrepancies observed
in the literature such as the enrolment of mild or moderate
ARDS patients in some trials. In a meta-analysis [5] the
authors stratified seven trials on prone positioning in
ARDS on the basis of high or low tidal volumes. Prone
positioning was associated with a significant decrease in
the relative risk of death only in studies using low base-
line tidal volume (B8 ml/kg PBW). This meta-analysis
suggested that tidal volume is a potential confounding
factor in interpreting the results of prone position trials in
ARDS.
Another important issue about prone positioning is a
benefit–risk balance of potential adverse effects. In an
ancillary study of the PROSEVA trial [6], it was shown
that the rate of pressure ulcers was higher in the patients
who were positioned prone vs. controls, in particular
those ulcers involving the face and the anterior part of the
thorax. The use of prone positioning, male gender, higher
age, body mass index and SAPS II score at admission
were all independently associated with the risk of devel-
oping a pressure ulcer. This study clearly suggested that
the use of prone positioning should be done according to
well-defined medical and nursing protocols in each ICU
using this technique.
In a review paper, Pinsky [7] summarized the effects
of PEEP on right ventricular function. A rapid increase in
central venous pressure while right ventricular systolic
volume does not increase suggests that right ventricular
failure is present. Lung-protective strategies aimed at
decreasing lung overdistension favourably impact right
ventricle performance. Under these circumstances right
ventricular dysfunction remains associated with a worse
outcome. Inhaled nitric oxide (iNO) may reduce right
ventricular afterload, but the use of iNO remains contro-
versial in ARDS patients. Despite being effective in
improving oxygenation in some patients, all trials have
concluded that iNO does not improve the outcome of
ARDS patients, and impaired renal function may be a side
effect. However, as stressed in a review [8], there is the
need to evaluate the use of iNO during lung-protective
ventilation as a rescue therapy prior to ECMO when
mechanical ventilation and prone positioning have failed
to improve gas exchange.
An important issue regarding ECMO use in ARDS
patients is the need to develop useful tools to select pa-
tients who could benefit. Indeed, the development of
mobile units is associated with extra costs and it is of
upmost importance to correctly predict the outcome on
the basis of easily obtainable parameters. The most recent
scores were detailed and compared in a review [9, 10].
ECMO initiation after more than 7 days of mechanical
ventilation and the presence of extra-pulmonary organ
dysfunction are consistently associated with poorer out-
come. There is, however, a need to validate these scores
in studies including patients from ICUs worldwide.
Airway management, ventilation and sedation
Mosier and Law [11] updated recent findings about air-
way management in critically ill patients. They
highlighted the importance of pre-intubation evaluation
for potential difficulty [12] and appropriate planning and
implementation of guidelines [13], positioning, pre-oxy-
genation [13] and, in selected patients, the use of a
neuromuscular blocking agent have been shown to be
useful for minimizing the difficult intubation and intu-
bation-related complications [13]. Although there are
controversies regarding the use of video laryngoscopy as
the primary method of intubation, it has been shown to be
at least as good as, and often more successful than, direct
laryngoscopy [14, 15].
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De Jong et al. [15] systematically reviewed and meta-
analysed RCTs and prospective [14] and retrospective
observational studies of video laryngoscope vs. direct
laryngoscope (DL) in adults who were intubated in the
ICU. Nine trials with a total of 2,133 participants (1,066
in VL and 1,067 in DL) were included in the analysis.
Compared to direct laryngoscopy, video laryngoscope
reduced the risk of difficult intubation [OR 0.29 (95 %
confidence interval (CI) 0.20–0.44)], Cormack grade 3/4
[0.26 (0.17–0.41)], oesophageal intubation [0.14
(0.02–0.81)] and increased the first-attempt success rate
[2.1 (1.4–3.2)]. No statistically significant differences
were found for severe hypoxaemia, cardiovascular col-
lapse or airway injury.
Graciano et al. [16] evaluated the incidence and as-
sociated risk factors of difficult tracheal intubations in
paediatric ICU. They used data collected prospectively
from 15 paediatric ICUs related to tracheal intubation for
the National Emergency Airway Registry for Children
(NEAR4KIDS). A total of 1,516 oral tracheal intubations
were reported (median 2 years of age) and 97 % of pa-
tients were intubated with direct laryngoscopy. Difficult
tracheal intubation was reported in 9 % of intubations and
was associated with a higher incidence of oxygen de-
saturation less than 80 % (48 vs. 15 %, p \ 0.001),
adverse tracheal intubation-associated events (53 vs.
20 %, p \ 0.001) and severe tracheal intubation-associ-
ated events (13 vs. 6 %, p = 0.003). A history of difficult
airways and sign of upper airway obstruction were asso-
ciated with difficult tracheal intubation.
Serpa Neto et al. [17] performed an individual patient
data meta-analysis of seven studies (2,184 patients) to
assess the associations between tidal volume size, dura-
tion of mechanical ventilation and need of sedation in
patients without ARDS. Patients were assigned to three
groups based on tidal volume size (B6, 6–10 and C10 ml/
kg PBW). The number of patients breathing without as-
sistance by day 28 was higher in the group ventilated with
tidal volume B6 ml/kg PBW as compared to those ven-
tilated with tidal volume C10 ml/kg PBW (93 vs. 89 %;
p = 0.03). Only two studies (187 patients) could be in-
cluded in the meta-analysis of need of sedation. There
were no differences in number of days patients received
sedatives, opioids or neuromuscular blocking agents, or in
the total dose of any of these drugs. The results suggest
that use of lower tidal volumes in patients without ARDS
at the onset of mechanical ventilation could be associated
with shorter duration of ventilation. Use of lower tidal
volumes seems not to affect sedation or analgesia needs,
but this need to be confirmed in a robust well-powered
RCT.
Negative pressure pulmonary oedema may be more
common in ICU patients than is thought. Ventilation with
low tidal volume in patients with increased respiratory
drive may lead to patient–ventilator asynchrony that
causes increased breathing effort and the generation of
high negative inspiratory pressures that will further
worsen pulmonary oedema [17].
Non-invasive ventilation
In 2014, studies assessed the use of non-invasive venti-
lation (NIV) in medical [18, 19] and surgical [20, 21]
patients. Lorut et al. [22] reported a large multicentre
RCT that investigated whether systematic postoperative
NIV vs. standard care prevented respiratory complications
following lung resection in a selected population of 349
COPD patients. NIV was delivered intermittently through
facial or nasal masks 6 h per day for 48 h postoperatively.
The rates of acute respiratory events (primary endpoint)
or acute respiratory failure were not different between the
NIV and control group. Rescue NIV was used less in the
NIV group, but re-intubation rates were not different
between the groups. Mortality rates were low in both
groups. This paper was accompanied by an editorial [23],
which gave some possible explanations for the lack of
beneficial effects. In the postoperative period, it is
sometimes difficult to clearly separate ‘‘preventive’’ and
‘‘curative’’ application of NIV. Probably some of the
patients received NIV for ‘‘grey zone’’ indications (at the
time of starting NIV and also after) which may be con-
sidered as an intermediary state between ‘‘preventive’’
and ‘‘curative’’ application of NIV [23]. Further studies
are needed to better identify the patients who may benefit
from NIV after thoracic surgery and the optimal NIV
protocol (duration, settings, interfaces and humidification
systems use for gas conditioning).
Lellouche et al. [24] assessed the impact of the type of
humidification system used on the success rate of NIV
using ICU ventilators for ARF in an RCT. This interna-
tional RCT included 247 patients, 128 of whom were
allocated to a heat and moisture exchanger (HME) group
and 119 to a heated humidifier (HH) group. There was no
significant difference in the intubation rates (the primary
endpoint) between the HH and HME groups (37 vs. 30 %,
respectively, p = 0.28). No significant difference was
observed for NIV duration, ICU and hospital LOS or ICU
mortality. In addition, no difference in the patients’ mu-
cosal dryness was reported with HH in comparison with
HME. These results suggest that despite a strong
physiologic rationale supporting the use of HH during
NIV [25], this method cannot be recommended as a first-
line treatment in all patients with ARF. The use of an
HME (ideally with a low dead space) while removing the
additional dead space (flex-tubing) seems to be acceptable
in light of the results of this study. Finally, contrary to
recommendations published in 2012 that propose HH for
NIV rather than HME, the authors found no difference in
outcomes. However, in the presence of persistent high
PaCO2 levels associated with threatening encephalopathy,
the reduction of dead space with an HH may be
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considered. This paper was accompanied by an editorial
[26] which asked the question why a trial that finished
enrolling patients in December 2003 would be published
10 years later. The authors of this editorial [26] empha-
sized that every reasonable attempt should still be made to
publish the data.
Brambilla et al. [19] evaluated the efficacy of non-
invasive continuous positive airway pressure (CPAP) to
improve outcomes in severe hypoxaemic ARF (hARF)
due to pneumonia in an RCT conducted in four Italian
centres. Patients were randomised to receive helmet
CPAP (CPAP group, n = 40) or oxygen delivered with a
Venturi mask (control group, n = 41). Helmet CPAP
reduced the risk of reaching criteria for endotracheal in-
tubation (the primary endpoint) as compared to oxygen
therapy (6/40 = 15 % vs. 26/41 = 63 %, respectively,
p \ 0.001). The CPAP group also showed faster and
greater improvement in oxygenation in comparison to
controls. In either study group, no relevant adverse events
were detected; two patients were intubated in the CPAP
group and one in the control group.
Schnell et al. [18] evaluated the use and outcomes of
NIV over a 15-year period (1997–2011) from a multi-
centre database of critically ill patients who required
ventilatory support for ARF. The impact of first-line NIV
on 60-day mortality was evaluated using a marginal
structural model. Of 3,163 patients, 1,232 (39 %) patients
received NIV. Over the study period, use of first-line NIV
increased from 29 to 42 % and NIV success rates in-
creased from 69 to 84 %. NIV decreased 60-day
mortality, and this was observed mainly in patients with
acute-on-chronic respiratory failure, but not in patients
with cardiogenic pulmonary oedema, or in patients with
hARF (both immunocompetent and immunocompro-
mised). NIV failure was an independent, time-dependent
risk factor for mortality. The authors emphasized that
further studies are warranted on early predictors of NIV
failure to help in selecting patients for NIV [27, 28].
Weaning
In their ‘‘Our paper 20 years later’’ Frutos-Vivar and
Esteban described how withdrawal from mechanical
ventilation has changed. At the beginning of the 1990s,
there was little evidence regarding the best method of
withdrawing patients from mechanical ventilation. Today,
withdrawal from mechanical ventilation (or weaning) is
one of the most common procedures in ICU. Esteban
et al. [29] published one of the seminal papers on weaning
in which they reported that the best method for with-
drawal from mechanical ventilation in difficult-to-wean
patients was a once-daily spontaneous breathing trial with
a T-piece. Following this study [29, 30], several other
studies [31] have shaped weaning as an evidence-based
technique. The results of these studies [29, 32] have been
applied progressively to clinical practice. Currently, the
withdrawal from mechanical ventilation could be sum-
marized as the performance of a spontaneous breathing
trial to evaluate extubation readiness (this trial could be
performed with a T-piece, which occurs most commonly,
or with CPAP or low levels of pressure support). Most
patients could be disconnected after passing the first
spontaneous breathing trial. In patients who failed the first
attempt at withdrawal, the use of a once-daily sponta-
neous breathing trial or a gradual reduction in pressure
support is the preferred weaning method. However, new
applications of the standard techniques, such as NIV, or
new methods of mechanical ventilation, such as automatic
tube compensation, automated closed-loop systems and
automated knowledge-based weaning systems could play
a role in the management of the patients with difficult or
prolonged weaning. In the future, studies should better
evaluate the relationship between the implementation of
protocols for the optimization of sedation and weaning
outcomes. Moreover, the focus should be on the rela-
tionship between ICU-acquired weakness and weaning
failure. An early mobilization of patients could be pro-
posed for the prevention or early therapy of ICU-acquired
weakness associated with mechanical ventilation wean-
ing-sedation protocols.
Adjuvants in sepsis
The use of statins in sepsis is very controversial. Recent
evidence suggests that there is no indication for using
statins either in infection or ARDS in ICU patients. The
dose and the potency of statins could be important factors.
In a cohort study including more than 50,000 patients
from Taiwan [33], a propensity score-based analysis
concluded that the use of high-potency statins (C10 mg
rosuvastatin, C20 mg atorvastatin, C40 mg simvastatin)
was associated with reduced 1-year mortality as compared
to non-statin users and low-potency statin users.
Recombinant human IL-7 (rhIL-7) may be a potential
therapeutic intervention for sepsis. Investigators have
demonstrated that rhIL-7 has beneficial effects both in
terms of mortality and immune dysfunction in mice models
[34] and restoring sepsis-induced human lymphocyte
functions to a normal response in an ex vivo study [35].
Demaret et al. [36] evaluated the association of soluble
plasmatic levels of CD127 (sCD127), an IL-7 receptor, and
mortality in 70 septic patients. They demonstrated that
sCD127 levels were independently associated with mor-
tality and could discriminate survivors from non-survivors
(area under ROC curve = 0.85).
Ulinastatin is a serine protease inhibitor that inhibits
several pro-inflammatory proteases and decreases in-
flammatory cytokine levels and mortality in experimental
sepsis. In a pilot trial (n = 114), intravenous ulinastatin
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was associated with reduced organ failures and mortality
in patients with severe sepsis [37].
The long-term outcomes were reported from the 6S trial
on HES 130/0.42 vs. Ringer’s acetate in 804 patients with
severe sepsis. Mortality rates at 1 year did not differ be-
tween the two intervention groups, but a clinically relevant
decrease in mortality with starch could be rejected [38].
A computer decision support system (CDSS) fa-
cilitating blood glucose control has been suggested to
improve the outcome of ICU patients through tighter
control. A randomised trial of 2,684 ICU patients failed to
show improved outcome in patients managed with a
CDSS vs. control. Moreover use of CDSS was associated
with more events of severe hypoglycaemia [39].
The gastrointestinal tract is pivotal in regulating in-
sulin secretion and glycaemia. It is now understood that
the incretin effect is due to two hormones, glucagon-like
peptide 1 (GLP-1) and glucose-dependent insulinotropic
peptide (GIP). These hormones may have therapeutic
potential by lowering blood glucose and reducing gly-
caemic variability with no risk of hypoglycaemia, which
may be of particular benefit in the critically ill [40].
Hepatic failure
‘Acute-on-chronic’ liver failure has high infection rates,
which are associated with mortality. A proposed model
implies that the markedly increased risk of infection is
due to systemic translocation of microbes from the gut,
impaired hepatic clearance mechanisms and decreased
ability of circulating immune cells to combat infectious
cues (peripheral immune-paresis) [41].
New knowledge also advances our understanding of
the pathophysiology of acute liver failure (ALF). ALF
causes massive ‘‘spillover’’ of cytokines to the circulation
causing SIRS in the initiation/propagation phase and
compensatory anti-inflammatory response (CARS) there-
after. Persistent CARS response is linked to recurrent
infections complicating ALF, conferring a poor progno-
sis. SIRS and CARS further affect other organ systems,
e.g. circulating inflammatory mediators crossing the
blood–brain barrier and they induce encephalopathy/
cerebral oedema through microglial activation [42].
Larsen and Wendon [43] reviewed the recent literature
on paracetamol-induced liver toxicity, one of the most
frequent causes of acute liver failure worldwide. In ad-
dition to severe liver dysfunction, the patients often have
shock, lactic acidosis, kidney injury, coagulopathy and
encephalopathy. Drug toxicity profile as well as patho-
physiological mechanisms were reviewed. The treatment
of paracetamol-induced liver toxicity consists of N-
acetylcysteine and supportive care in the ICU, but there
are only few randomised trials of its management. Liver
transplantation, including supportive care with albumin
dialysis and plasma exchange, should be considered in the
most severely ill patients.
Symptoms assessment and management
An essential task for ICU staff is to acknowledge and
relieve physical and emotional suffering in patients and
their relatives. Schmidt et al. [44] performed a compre-
hensive review on dyspnoea, an unrecognized or at least
underestimated suffering in mechanically ventilated pa-
tients. The prevalence of dyspnoea varied between 11 and
100 % among the eight prospective studies included.
Mechanically ventilated patients qualified the sensation of
dyspnoea as ‘‘moderate to intense’’ and it could even
reach unbearable levels necessitating the administration
of analgesics according to some studies. Dyspnoea was
also associated with anxiety and delayed psychological
sequelae such as recollections of ICU experiences and
post-traumatic stress disorder (PTSD), all important
deleterious consequences; consequently, we must keep in
mind that dyspnoea can often simply be improved by
altering ventilator settings. The authors concluded that
future studies are needed to better delineate the impact of
dyspnoea in ICU and to define diagnostics, monitoring
and therapeutic protocols.
PTSD also appears to be common among ICU sur-
vivors, and symptoms of PTSD can persist for many
months after recovery from critical illness. Long et al.
[45] created a conceptual model that integrates know risk
factors and current evidence regarding potential strategies
to reduce symptoms of PTSD. Until reliable and validated
screening tools are developed, clinicians should be aware
of the potential modifiable and non-modifiable risk factors
that are associated with PTSD among ICU survivors.
Puntillo et al. [46] conducted a single-blinded, ran-
domised trial in three ICUs testing a bundle targeting
thirst intensity, thirst distress and dry mouth, which are
among the most pervasive, intense, distressful symptoms
among ICU patients. A total of 252 cognitively intact
patients reporting thirst intensity and thirst distress were
randomised to the thirst bundle or usual care. A research
nurse administered a thirst bundle that included oral swab
wipes, sterile ice cold water sprays and a lip moisturizer
for patients in the intervention group. Another research
nurse, blinded to group assignment, obtained pre- and
post-procedure thirst scores. The simple, inexpensive
thirst bundle significantly decreased ICU patients’ thirst
and dry mouth as compared to the usual care group.
Roulin and Ramelet [47] conducted a study in brain-
injured ICU patients to describe their behaviour during rest,
a non-nociceptive procedure (calling and shaking shoul-
ders) and a nociceptive procedure (turning the patient).
393
Patients with absence of movement or those with reflexive
flexion or extension responses to a nociceptive stimulus
displayed more behaviour during turning than patients with
localized responses or patients able to self-report their pain.
Face flushing, clenched teeth, clenched fist and tremor were
more frequent in patients with stereotyped responses to a
nociceptive stimulus. The reliability of their checklist was
high and the internal consistency was acceptable. Dis-
criminant and concurrent validity was also supported. This
study suggests that brain-injured patients react significantly
more during a nociceptive stimulus and the number of ob-
served behaviours was higher in patients with a stereotyped
response.
Pressure ulcers are frequent in ICU patients and are
associated with adverse outcome and increased costs. A
strategy aimed at increasing repositioning frequency
(every 2 vs. 4 h) in patients undergoing mechanical
ventilation did not, however, reduce the incidence of
pressure ulcers in a recent randomised trial [48].
Palliative care and support for families
Relieving physical and emotional suffering becomes
particularly important at end of life. On behalf of the
Interdisciplinary Advisory Board of the Improving Pal-
liative Care in the ICU (IPAL-ICU) project, Puntillo et al.
[49] performed a comprehensive review on palliative care
in the ICU focusing on assessing and relieving pain,
dyspnea and thirst. Evidence-based methods to assess
pain are the enlarged 0–10 numeric rating scales (NRS)
for ICU patients able to self-report and the critical care
pain observation tool or Behaviour Pain Scale for patients
who cannot report symptoms verbally or non-verbally.
These validated scales and the relationship between pain,
anxiety and fear were further explored in a ‘‘What’s new
in intensive care’’ article by Ge´linas et al. [50]. The
Respiratory Distress Observation Scale is the only known
behavioural scale for assessment of dyspnoea, and thirst is
evaluated by patient self-reporting using a 0–10 NRS.
Optimally titrated opioids remain the mainstay for pain
management while dyspnoea should be treated by opti-
mizing the underlying etiological condition, patient
positioning and sometimes supplemental oxygen. Finally
several oral interventions are recommended by Puntillo
et al. [49] to alleviate thirst. The authors insist that the
quality of care should be monitored in order to improve
the assessment and management of these important
symptoms.
Long et al. [51] hypothesized that the quality of end-
of-life care for patients admitted to the ICU from the
hospital ward was lower than that observed among pa-
tients admitted from the emergency department (ED).
They conducted a cohort study of patients with an un-
derlying chronic illness who developed acute respiratory
failure and subsequently died in the ICU in one of 14
hospitals. They compared the family satisfaction with
care and quality of dying as assessed by the family and
the ICU nurses, as well as quality of palliative care
assessed from the medical record. Admission from the
hospital ward was associated with lower family ratings of
quality of dying and satisfaction than admission from the
ED. Interestingly, nurses did not report differences in
quality of dying. In addition, patients admitted to the ICU
from hospital wards were less likely to have family
conferences or discussion of prognosis in the first 72 h
after ICU admission, but were more likely to have life
support withdrawn. The authors conclude that admission
from the hospital ward is associated with family percep-
tions of lower quality of dying and less satisfaction with
ICU care. Differences in receipt of palliative care suggest
that family of patients from the hospital wards receive
less information.
Sleepiness and fatigue are commonly reported by
family members of ICU patients and sleep deprivation
causes cognitive deficits. Verceles et al. [52] published a
multicentre, cross-sectional survey of family members of
patients admitted to ICUs at three hospitals. Family
members of ICU patients were evaluated using the Ep-
worth Sleepiness Scale, a standard survey assessing
sleepiness, and the Functional Outcomes of Sleep Ques-
tionnaire-10, which quantifies the impact of sleepiness on
daily activities. They assessed 225 family members and
50 % had Epworth scores consistent with excessive day-
time sleepiness and they experienced greater impairment
in performing daily activities. This study suggests that
half of the family members of ICU patients suffer from
excessive daytime sleepiness and that this sleepiness is
associated with functional impairment.
In a ‘‘What’s new’’ article, Giannini et al. [53] address
the issue of limitations on family visits in the ICU. In the
past few years several consensus groups have recom-
mended liberal visiting policies in ICU. Nevertheless,
these recommendations have not significantly influenced
clinical practice in many countries. The authors argue that
by welcoming families and visitors in ICU we, as ICU
doctors and nurses, are not making a concession to the
patient or family, but instead we are recognizing the rights
of the patient. The authors make a compelling argument
that by opening our ICUs for family visits, we can make a
difference for patients and families. The complex and
highly technological environment of the ICU can and
should become a welcoming place, which respects the
needs of patients and families, and where ‘‘humanity has a
high priority’’.
In a commentary, Curtis et al. [54] identify some ex-
amples of words or phrases in the English language that
are commonly used in communicating with patients,
families and colleagues and which the authors believe can
convey unintended negative messages or which can be
confusing to those with whom we are communicating.
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Terms such as withdrawing care can imply that clinicians
will no longer care for or about patients and their families.
Instead, clinicians should talk about ‘‘withdrawing life-
sustaining treatments’’. These and other examples provide
suggestions for clinicians in using words to be sure that
their true intentions are understood.
Jabre et al. [55] investigated the incidence of late
psychological burden among family members system-
atically given the option to witness CPR of a relative as
compared with those not routinely offered the option in a
cluster-randomized trial in France. The study nicely
demonstrated that the proportions of family members
experiencing symptoms related to PTSD (32 vs. 20 %,
p = 0.01), major depressive episodes (31 vs. 23 %,
p = 0.02) and complicated grief (36 vs. 21 %, p = 0.005)
were significantly higher in the control vs. the interven-
tion group. Similar results were observed among family
members to whom physicians did not propose the op-
portunity to witness resuscitation.
Prognostication
While of course saving lives is clearly the heart of our
mission, we should not forget that good ICU practice
starts with appropriate triage decisions. Prognostic indi-
cators associated with long-term outcomes from large
multicentre cohorts may help us in making such deci-
sions. Wang et al. [56] identified predictors of 1-year
mortality among 493 ALI/ARDS hospital survivors ad-
mitted between 2006 and 2010 in multiple units at the
Vanderbilt University Medical Center. Mortality in-
creased from 24 % at hospital discharge to 41 % at
1 year. Patients who died after discharge were older and
more likely to have been discharged to a nursing home,
another hospital or hospice as compared to those who
survived to 1 year. Important predictors of mortality were
age, comorbidities such as HIV, metastatic and non-
metastatic cancer, hematologic malignancy and chronic
kidney disease present at the time of admission and not
living at home prior to admission. The authors concluded
that 1-year mortality is essentially affected by non-
modifiable factors and that therefore these factors should
be taken into account when testing new interventions in
ARDS and improving guidance in the offering of full
resuscitation for high-risk patients and in the discussions
of prognosis with the relatives.
That critically ill patients with solid cancer have worse
prognosis than critically ill patients without any comor-
bidity is rather straightforward. Puxty et al. [57]
performed a systematic review on survival in ICU patients
with solid cancer. They identified 35 and 31 studies re-
porting ICU and hospital survival representing a total
sample of 25,339 and 74,061 patients, respectively. The
average ICU and hospital mortality was 31 % (95 % CI
24–39 %) and 38 % (34–43 %), respectively, the latter
ranging from 5 to 77 %. Worse functional status and
severity of illness scores and invasive mechanical venti-
lation were associated with increased mortality.
Another important factor beside age and underlying
comorbidities is frailty. Le Maguet et al. [58] assessed the
prevalence and impact of frailty on ICU and 6-month
mortality in 196 patients aged at least 65 years admitted
across four French hospitals between November 2011 and
May 2012. Frailty was defined as either a clinical frailty
score C3 or a frailty phenotype C5. Of the 46 patients
fulfilling the first or both definitions of frailty only 30 %
were still alive at 6 months as compared to about 75 % of
42 patients fulfilling the second definition only or the 108
patients without frailty (p \ 0.01). Frailty was an inde-
pendent predictor of 6-month mortality after adjustment
for classical confounders. Although comorbidities, older
age, frailty and not living at home prior to admission
alone could not fully discriminate between long-term
survivors and non-survivors, these studies indicate that
these factors should be taken into account during triage
discussions with the patient, relatives and attending
physicians.
Besides differences in ventilator strategies, differences
in triage decisions among many other confounders may
explain the differences in outcome observed across ICUs
in the UK with low vs. high volume mechanically ven-
tilated admissions. In a retrospective study of 120,293
adult patients admitted between 2008 and 2010 in 193
ICUs, Shahin et al. [59] found a significant relationship
between annual volume and hospital mortality (p \ 0.02).
They found a strong interaction between annual volume
and admission type, with a more pronounced volume
outcome relationship for non-surgical admission
(p \ 0.001). The interaction between annual volume and
initial severity of respiratory failure was not statistically
significant. These findings were, however, sensitive to the
modelling used.
The management and outcomes of human immun-
odeficiency virus (HIV)-infected patients have changed
dramatically over the two last decades. However, infor-
mation in the setting of critical illness requiring ICU
admission occurring in these patients is scarce and mostly
restricted to single-centre studies. Barbier et al. [60]
evaluated 6,373 consecutive patients admitted to 34
French ICUs over a 12-year period using the CUB-Re´a
Database. They observed significant changes in patients’
profiles and outcomes over time. Patients admitted more
recently were older, had more co-morbidities and were
more frequently on mechanical ventilation (MV) and re-
nal replacement therapy (RRT). Overall use of MV and
RRT and ICU and hospital mortality rates decreased
significantly over time. Delayed ICU admission ([24 h)
was associated with increased mortality (OR 1.7, 95 % CI
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1.2–2.5). Interestingly, most of the HIV-related compli-
cations were not associated with worse outcomes.
In subgroup analyses of the Target Temperature Man-
agement trial, mortality did not differ between patients with
shock after out of hospital cardiac arrest managed to a target
temperature of 33 vs. 36 C for 24 h [61]. However, car-
diovascular failure was more pronounced after
randomisation in the patients cooled to 33C.
Organ donation
Lesieur et al. [62] conducted an observational study de-
signed to assess the theoretical eligibility as organ donors
of patients dying in French ICUs after a decision to
withhold or withdraw life-sustaining therapy. They col-
lected data on patients admitted to 43 ICUs who qualified
for withholding or withdrawing life-sustaining therapy.
The theoretical organ donor eligibility of deceased pa-
tients was determined by medical criteria for graft
selection and according measures withheld or withdrawn
and the impact on time to death. A total of 5,589 patients
were admitted to the ICU, of which 777 (14 %) patients
underwent withholding or withdrawing of life-sustaining
therapy. Of the 557 patients who died after a foreseeable
circulatory arrest, 278 patients (50 %) presented a con-
traindication to organ retrieval; 279 patients would have
been eligible as organ donors. Yet, cardiopulmonary
support was withdrawn in only 154 of these patients, 70
of whom died within 120 min of the withdrawal. Brain-
injured patients accounted for 29 % of all patients who
underwent withholding or withdrawal of life-sustaining
therapy and 57 % of those died within 120 min of the
withdrawal. The authors concluded that a significant
number of patients who died in French ICUs after a de-
cision to withhold or withdraw life support would have
been eligible for organ donation. They also found that
brain-injured patients were more likely to die in circum-
stances which would have been compatible with organ
donation.
In a ‘‘What’s new’’ article, the Shaw and Elger [63]
made the case that, used properly, persuasion can be a
supportive mechanism to counsel family members to al-
low organ donation without unethical coercion. It can be
ethical, the authors argued, to use persuasion to help
families deal with the stress of a decision to permit do-
nation. Doing so may allow us to respect patients’
autonomy when they have expressed support for organ
donation. The authors pointed out that families asked
about this decision should be given the information
relevant to their decision; if the deceased was a registered
donor, they should be provided this information. If
families may be unaware of the potential benefits of do-
nation, these benefits should be described. The authors
argued that if family members offer inconsequential or
inaccurate reasons to forego organ donation, they should
be persuaded of the problems or inaccuracies of such
reasons. Furthermore, they also argue that family mem-
bers should be informed that many families who refuse
consent for organ donation ultimately come to regret that
decision. Others have suggested that families’ decisions
regarding donation should not be challenged as they are
distressed over the loss of a loved one, but the authors
argued that to compound their difficulty with decision-
making by withholding key information is to disrespect
the family and patient.
Outcomes
As patient-centred care brings a new focus to short- and
longer-term outcomes, there is increasing interest in
which measures are most informative and integrative.
Using the 6MWD as the main comparator, Denehy et al.
[64] analysed how other activity-based measures serve as
proxies. The study sample consisted of 177 ICU survivors
recruited from acute care hospitals in Australia and the
USA. The authors showed good correlation between the
6MWT and the time up and go test, the Berg balance
scale and the 59 sit to stand test. The 6MWT explained
54 and 33 % of the variance in the physical part of SF-36
and no clinical variables were significant predictors.
6MWT is one important integrative outcome measure but
is of limited utility in those patients unable to walk or
severely disabled after critical illness. Choice of outcome
measures should be aligned with the study question and
capture global disability.
ECMO is a scarce resource and risk stratification for
outcome is important and a key issue when patients are
retrieved from referral centres. Roch et al. [65] sought to
identify patient factors that were associated with un-
favourable early outcome in patients retrieved and offered
ECMO. Based on a multivariable logistic regression model,
a risk score including age, SOFA score and influenza
pneumonia, was constructed. The probability of hospital
mortality following ECMO initiation was 40 % in the 0–2
score class and 93 % in 3–4 score class with increased age
and SOFA score associated with increased risk and a di-
agnosis of influenza protective of death in hospital. These
simple criteria may help to inform bedside decision-making
during retrieval for ECMO. Single-centre data and the ho-
mogeneity of admitting diagnosis (CAP and influenza)
limit the generalizability of these findings.
Functional disability and cognitive impairment after
critical illness have been well described. Some gains have
been made in the application of post-ICU physical, occu-
pational and cognitive therapy interventions. However,
cognitive therapy protocols for administration during the
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ICU have not been evaluated. In a feasibility study,
Brummel et al. [66] randomised 87 medical and surgical
ICU patients with respiratory failure or shock to three
groups: usual care, early once-daily physical therapy or
early once-daily physical therapy plus a novel twice-daily
cognitive therapy protocol. These authors showed that ad-
ministration of complex multi-modality ICU-based
interventions had good compliance and was feasible. There
were no differences in cognitive, functional or HRQoL
outcomes at 3 months but the study was not powered to
determine efficacy for the intervention. This work shows
the crucial importance of investing in early pilot work to
inform issues related to compliance, feasibility, safety,
choice of optimal outcome measures and refinement of
sample size and statistical power calculations.
A poignant contribution by Laghi et al. [67] was part of
the unique Intensive Care Medicine series titled ‘‘My paper
20 years later’’ in which content experts are invited to
discuss a more historical work in the context of the current
literature and the importance and implications of their early
observations. In 1995, these authors published a seminal
paper in the Journal of Applied Physiology in which they
assessed the time course of recovery from diaphragmatic
fatigue. They described the persistence of significant fa-
tigue—defined as an effort-induced decrease in muscle
contractility that recovers after rest—at 24 h after induction
in healthy volunteers. This landmark observation became
the tenet of the once-daily, T-tube trial arm in RCTs for
ventilator weaning in the ICU and helped to inform the
design of a trial of weaning for tracheostomy patients re-
quiring prolonged mechanical ventilation. Further, this
work elucidated low-frequency fatigue and the introduction
of twitch airway pressure to document the prevalence and
outcome of respiratory muscle weakness. These authors
rightly assert that there remains a pivotal role for basic
physiology studies as part of the spectrum of research that
continues to inform practice in mechanical ventilation and
the care of critically ill patients.
Organisation
The literature is sparse on supply of acute care services in
low-income settings. Such information is essential to
guide investments in infrastructure and services to meet
the burden of acute diseases, particularly in large urban
centres. To address this gap, Austin et al. [68] assessed
the acute care services supply (hospitals, hospital beds,
ICU beds, ambulances) in seven cities of diverse eco-
nomic background in Europe, Africa, Asia and North and
South America. They demonstrated that there were large
variations in the supply of acute care services, which
correlated only in part with the countries’ gross domestic
product. However, some measures of supply (e.g. hospital
beds, self-defined ICU beds) were comparable in high-
and upper-middle-income cities. Another important find-
ing was that such information frequently is not easily
available from governments, with potential implications
for future planning, particularly in middle-income coun-
tries as these are facing the largest population growth
projections.
Quality improvement programs focusing on early
recognition and adherence to best practices are the key to
improving quality of care and outcomes in patients with
sepsis. In this context, Noritomi et al. [69] reported the
results on the implementation of a multifaceted quality
improvement program (including screening strategies,
multidisciplinary educational sessions, case management
and continuous performance assessment) in a private
network of 10 hospitals in Brazil using a pre- and post-
intervention study design. They evaluated the approach in
2,120 patients with severe sepsis or septic shock, and
demonstrated significant increases in the compliance to
the resuscitation bundle of the Surviving Sepsis Cam-
paign (13 vs. 62 %, p \ 0.001) and hospital survival (45
vs. 74 %, p \ 0.001) in the ‘‘post-interventional’’ period.
More importantly, the strategy proved to be cost-effec-
tive. The results of this study may be of particular
relevance for emerging countries where sepsis mortality
rates remain disproportionally high [70].
Adequate prophylaxis is essential to prevent venous
thromboembolic disease (VTE) in ICU patients, par-
ticularly in those at high risk. The PROF-ETEV study
evaluated current practices regarding the appropriateness
of prophylactic measures in relation to the patients’ risk
for VTE in 777 patients admitted to several ICUs in Spain
[71]. The vast majority of patients had multiple risk fac-
tors for VTE and 83 % were at very high risk.
Nevertheless, prophylaxis was inappropriate in 23 % of
medical, 71 % of surgical and 70 % of major trauma
patients according to guidelines criteria. This study rein-
forces that improvements should be enhanced regarding
identification of patients at risk and implementation of
appropriate preventive protocols.
The identification of patients at increased risk of
delirium is paramount to optimize the implementation of
preventive strategies. In a multinational study involving
1,824 patients, van den Boogaard et al. performed a re-
calibration of PRE-DELIRIC, a delirium prediction
model for ICU patients [72]. Despite differences in the
studied predictors among the centres, PRE-DELIRIC had
good discriminative ability (area under ROC curve 0.77,
95 % CI 0.74–0.79). The authors concluded that subse-
quent validation studies of the PRE-DELIRIC model are
needed as this instrument may aid both the implementa-
tion of strategies to prevent delirium and improvements in
delirium management of ICU patients.
Grimaldi et al. [73] investigated whether the number
and the time course of circulating innate-like T lympho-
cytes correlated with the development of ICU-acquired
infections in critically ill patients, with a particular focus
397
on the recently identified innate-like mucosal-associated
invariant T (MAIT) lymphocytes. Innate-like lympho-
cytes lie between innate and adaptive immunity and
comprise B and T cells characterized by the recurrent
expression of antigen receptors with limited diversities.
Of note, MAIT lymphocytes display specific reactivity to
non-streptococcal bacteria. In this study, the authors ob-
served a significant early decrease in patients with severe
bacterial infections compared to both non-infected
critically ill patients and healthy control subjects. Con-
versely, NKT and cd T cell (other forms of innate-like
lymphocytes) counts did not differ among patients groups.
Moreover, non-streptococcal bacterial infection was in-
dependently associated with the decrease in MAIT cell
count, and patients with persistent MAIT cell depletion
had higher incidence of ICU-acquired infections.
Van Vliet et al. [74] used the Dutch National Intensive
Care Evaluation (NICE) registry to study 1,741 haema-
tological patients requiring ICU admission in more than
90 % of ICUs in the Netherlands between 2004 and 2012.
They reported average yearly decreases of 7 % in the risk-
adjusted mortality rates for both overall medical admis-
sions and among haematological patients, in parallel with
an increase in the proportion of admissions of haemato-
logical patients over time. This contemporary study also
reinforced that leukopenia was not associated with worse
outcomes in these patients.
Research methodology
Several papers were published that can help us in better
analysing and reporting study results. Alberti and
Boulkedid [75] focused on how to describe ICU data with
tables. Beside relatively straightforward recommenda-
tions about the type and presentation of tables, the authors
elaborate on much more important points for investigators
and readers such as determining appropriate measures of
central tendency and variability depending on the nature
of the variable (quantitative or qualitative variables, ra-
tios), effects size and inferential statistics, indication of
the denominators including in the setting of missing data,
specifying the appropriate arithmetic precision for quan-
tities, checking the total counts and percentages within
categories of variables and the internal coherence of
numbers/counts in the text, tables and figures among
many other issues.
Beyersman et al. [76] discussed how to measure and
report incidences in ICU populations. Incidence of events
occurring during ICU stay is typically calculated as the
incidence proportion (number of events/number of pa-
tients) or as incidence rate (number of incident
events/patients days). The latter may be preferred because
it accounts for the patient-time at risk. However, this
automatically implies that one has to consider also the
risks of observing competing events during ICU stay. For
instance ICU infections may not be observed as a result of
prior discharge from the unit. Similarly, death secondary
to infection or any other life-threatening event may not be
observed during ICU stay because of discharge from the
unit. In order not to present incomplete or misleading
results the authors recommend that investigators should
always calculate and report the incidence rates of such
competing events.
Labare`re et al. [77] provided a comprehensive narra-
tive but detailed overview on how to derive and validate
clinical prediction models before implementing them into
clinical practice. With the help of a 19-item checklist they
elaborate on (1) how to retrieve a derivation sample from
the original population in order to build an initial model
with good performance and internal validity, (2) how to
update and improve the model’s performance through
external validation and (3) how to test the additional value
of the predictive model as compared to standard of care at
the bedside by performing an impact analysis.
Rochwerg et al. [78] draw our attention to how ap-
propriately estimated and reported (average) effects sizes
retrieved from observational or randomised trials should
be implemented (at the individual level) at the bedside.
Although the quality of evidence based on the GRADE
rules and the balance between desirable and undesirable
effects are of course primordial to take account in clinical
practice guidelines, the authors convincingly argue that
no recommendation should trump common sense or
strongly held personal belief and that cost and resource
allocation should also be taken into consideration.
A systematic review found that non-registration (or
registration after trial completion) was common in RCTs
of critically ill patients. Moreover, among registered tri-
als, important protocol changes were often made between
trial commencement and publication. This identifies and
quantifies serious—but correctable—problems for RCTs
in critically ill patients [79]. Along this line, scepticism is
needed whenever research accomplishments are too good
to be true. The distinction between fraud, questionable
research practices, extravagant statistics and academic
misery can be subtle. False extravagant results are prob-
ably far more likely to arise from selective analysis and
outcome reporting and data dredging rather than by fraud
[80].
Appropriate interpretation of new results requires
awareness of emerging methodological issues. An un-
derstanding of the proper use of envelopes for
randomisation, appropriate covariate adjustment and the
need to impute missing baseline prognostic variables will
help clinicians identify trials that are less likely to report
false positive and/or false negative results [81].
In a ‘‘What’s new’’ article, Kompanje et al. [82] re-
viewed medical research and data protection in the
European Union (EU) by the Clinical Trial Directive
2001/20/EC and proposed changes to this directive. In
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most EU countries, prior consent by a legal representative
is used as a substitute for informed patient consent for
non-urgent medical research. Deferred consent by the
patient or surrogate decision-maker is accepted as a
substitute in acute emergency research in approximately
half of the EU countries. In 12 countries, emergency re-
search is not covered in national law. A proposal for a
regulation by the European Commission was recently
examined by the European Parliament and the Council
with the goal of replacing Directive 2001/20/EC. In this
proposal deferred patient and/or proxy consent is allowed,
but it does not support emergency research. For example,
in this proposal deferred consent is only possible when
legal representatives are not available. This proposal will
delay inclusion of patients in acute life-threatening con-
ditions in short time frames. As the proposal would be
binding in all member states, emergency research in acute
situations would be impaired by this proposal. Kompanje
et al. reviewed this proposal and some alternatives that
would better support clinical research in emergency
situations.
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